MPO and colitis: EVs derived from human placental MSCs have also been utilised to treat colitis, which markedly reduced intestinal inflammation and oxidative stress by dampening the activity of myeloperoxidase (MPO) and reactive oxygen species (ROS) [150] (Fig. 6).